Biotech firm I-Mab to divest China operations, shift focus to US

I-Mab said on Wednesday it has agreed to divest its operations and assets in China as part of its strategy to become a U.S.-focused biotech firm, sending the company's shares up nearly 11% in...

Related Keywords

Shanghai ,China ,Hangzhou ,Zhejiang ,Bengaluru ,Karnataka ,India ,Chinese ,Louise Chen ,Joseph Skelton ,Bhanvi Satija ,Shounak Dasgupta ,Hangzhou Co ,Cantor Fitzgerald ,Nasdaq ,I Mab Shanghai ,Greater China ,Markets ,